Intel shares jumped 10.8% on exceptionally high volume during the most recent trading session, marking one of the largest single-day gains in over two years. The surge came as investors reacted to a combination of renewed optimism around the company’s manufacturing roadmap and a wave of upward revisions to full-year revenue forecasts by several research firms. Trading volume exceeded the 30-day average by nearly 40%, underscoring strong institutional interest in the rally.

In August, the U.S. government converted CHIPS Act grants and defense funding into a 9.9% equity stake in Intel, committing approximately $8.9 billion to accelerate onshore chip fabrication. Since that transaction, Intel’s market capitalization has climbed more than 120% relative to the date of conversion, significantly outpacing the broader market’s return of under 8% over the same period. The strategic partnership grants the government a golden share with veto rights over key corporate actions, reinforcing Intel’s role in national security initiatives and domestic supply-chain resilience.

Despite the recent rally, consensus estimates for Intel’s next two quarterly earnings releases have been trimmed modestly, reflecting concerns over softer PC demand and ongoing production ramp-up costs at the new fabrication complex in Ohio. Analysts maintain a mixed stance: a majority rate the stock as a ‘moderate buy,’ pointing to partnerships with leading AI developers and an aggressive capex plan, while others advise waiting for a clearer improvement in gross margins before initiating positions. Intel’s forward price-to-earnings multiple of 54 remains well above the sector average, suggesting that further upside may hinge on continued execution against its 18A process node timeline.